State-backed vaccine manufacturer Biovac has revitalised its operations through significant partnerships and investment. The company has signed agreements with multinational pharmaceutical giant Sanofi and South Korean firm EuBiologics to produce vaccines for polio and meningitis. Additionally, Biovac has received a €10 million commitment from the French government. This funding is to expedite its work on an oral cholera vaccine. These…